
This study explored the role of DNA methyltransferase 3A (DNMT3A) in oral submucous fibrosis (OSF) and exposed oral fibroblasts to arecoline to mimic OSF and found that DNMT3A induced DNA hypermethylation in the von Hippel–Lindau (VHL) promoter. This led to OSF development by increasing oral fibroblasts' viability, invasiveness, and migration. Understanding these mechanisms may open avenues for novel OSF treatments.
Like
Save
Share